| Svetlana S Matayev, MD | |
|
9610 Metropolitan Ave, Forest Hills, NY 11375-6625 | |
| (718) 459-0400 | |
| (718) 663-5789 |
| Full Name | Svetlana S Matayev |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 22 Years |
| Location | 9610 Metropolitan Ave, Forest Hills, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699700351 | NPI | - | NPPES |
| 02818037 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 236272 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Long Island Jewish Medical Center | New hyde park, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advantagecare Physicians Pc | 2365735008 | 321 |
News Archive
Concussions are common in young athletes but the underlying changes in brain function that occur have been poorly understood.
Aggressive treatment regimens successfully can treat nearly half of patients with extensively drug-resistant tuberculosis and can help prevent multi-drug resistant TB from developing into XDR-TB, according to a study conducted in prisons in Tomsk, Russia, and published Monday in the journal Lancet, Reuters reports. XDR-TB is resistant to the two most potent first-line treatments and at least two of the classes of second-line drugs.
SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing. SutroVax is developing vaccines for infectious disease targets, with an initial emphasis on best-in-class conjugate vaccines, using an exclusive license to Sutro Biopharma's Xpress CF and Xpress CF+ platforms for cell free protein synthesis and site-specific conjugation respectively.
Hamilton Storage is proud to introduce the new SAM HD, a low-capacity automated sample management system. SAM HD is the reliable, walkaway solution for labs seeking to transition from manual to automated sample storage.
BioData, producer of Labguru, the web-based research and lab management system, today announced that the Innovative Medicines unit of global pharmaceutical business, AstraZeneca, has adopted the Labguru platform for the global management of biological reagents used in pre-clinical research.
› Verified 7 days ago
| Entity Name | Advantagecare Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336578772 PECOS PAC ID: 2365735008 Enrollment ID: O20160719000446 |
News Archive
Concussions are common in young athletes but the underlying changes in brain function that occur have been poorly understood.
Aggressive treatment regimens successfully can treat nearly half of patients with extensively drug-resistant tuberculosis and can help prevent multi-drug resistant TB from developing into XDR-TB, according to a study conducted in prisons in Tomsk, Russia, and published Monday in the journal Lancet, Reuters reports. XDR-TB is resistant to the two most potent first-line treatments and at least two of the classes of second-line drugs.
SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing. SutroVax is developing vaccines for infectious disease targets, with an initial emphasis on best-in-class conjugate vaccines, using an exclusive license to Sutro Biopharma's Xpress CF and Xpress CF+ platforms for cell free protein synthesis and site-specific conjugation respectively.
Hamilton Storage is proud to introduce the new SAM HD, a low-capacity automated sample management system. SAM HD is the reliable, walkaway solution for labs seeking to transition from manual to automated sample storage.
BioData, producer of Labguru, the web-based research and lab management system, today announced that the Innovative Medicines unit of global pharmaceutical business, AstraZeneca, has adopted the Labguru platform for the global management of biological reagents used in pre-clinical research.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Svetlana S Matayev, MD 55 Water Street, 2nd Floor, New York, NY 10041-0004 Ph: (646) 680-2888 | Svetlana S Matayev, MD 9610 Metropolitan Ave, Forest Hills, NY 11375-6625 Ph: (718) 459-0400 |
News Archive
Concussions are common in young athletes but the underlying changes in brain function that occur have been poorly understood.
Aggressive treatment regimens successfully can treat nearly half of patients with extensively drug-resistant tuberculosis and can help prevent multi-drug resistant TB from developing into XDR-TB, according to a study conducted in prisons in Tomsk, Russia, and published Monday in the journal Lancet, Reuters reports. XDR-TB is resistant to the two most potent first-line treatments and at least two of the classes of second-line drugs.
SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing. SutroVax is developing vaccines for infectious disease targets, with an initial emphasis on best-in-class conjugate vaccines, using an exclusive license to Sutro Biopharma's Xpress CF and Xpress CF+ platforms for cell free protein synthesis and site-specific conjugation respectively.
Hamilton Storage is proud to introduce the new SAM HD, a low-capacity automated sample management system. SAM HD is the reliable, walkaway solution for labs seeking to transition from manual to automated sample storage.
BioData, producer of Labguru, the web-based research and lab management system, today announced that the Innovative Medicines unit of global pharmaceutical business, AstraZeneca, has adopted the Labguru platform for the global management of biological reagents used in pre-clinical research.
› Verified 7 days ago
Dr. John Depetrillo Jr., M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10201 66th Rd, Forest Hills, NY 11375 Phone: 718-830-4359 Fax: 718-830-1015 | |
Dr. Savi Mushiyev, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10250 62nd Rd Apt 3g, Forest Hills, NY 11375 Phone: 917-685-0804 | |
Sangam B Jhaveri, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 102-01 66th Road, Forest Hills, NY 11375 Phone: 718-806-1434 Fax: 718-806-1435 | |
Bella Sandler, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 7064 Yellowstone Blvd, Suite1,2, Forest Hills, NY 11375 Phone: 718-897-0900 | |
Dr. Daniel Horacio Wasserman, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11203 Queens Blvd, Suite 207, Forest Hills, NY 11375 Phone: 718-544-7077 Fax: 718-261-4476 | |
Dr. Ida Messana, M.D. , F.A.C.P. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 109-33 71 Road, Suite 2e, Forest Hills, NY 11375 Phone: 718-263-4345 Fax: 718-793-5607 | |
King-lee Chu, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 11045 Queens Blvd, Ste 107, Forest Hills, NY 11375 Phone: 718-268-8339 Fax: 718-268-8339 |